Key statistics
On Friday, Alzchem Group AG (ACT:DUS) closed at 156.20, -7.79% below its 52-week high of 169.40, set on Jan 12, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 153.80 |
|---|---|
| High | 157.20 |
| Low | 153.80 |
| Bid | 155.80 |
| Offer | 158.20 |
| Previous close | 153.60 |
| Average volume | 56.80 |
|---|---|
| Shares outstanding | 10.18m |
| Free float | 6.13m |
| P/E (TTM) | 25.39 |
| Market cap | 1.58bn EUR |
| EPS (TTM) | 6.10 EUR |
| Annual div (ADY) | 1.80 EUR |
|---|---|
| Annual div yield (ADY) | 1.17% |
| Div ex-date | May 09 2025 |
| Div pay-date | May 13 2025 |
Data delayed at least 15 minutes, as of Feb 20 2026 18:31 GMT.
More ▼
Announcements
- EQS-AFR: Alzchem Group AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
- EQS-DD: Alzchem Group AG: four two na GmbH, sell
- EQS-News: Alzchem Group AG paves the way for continuity and further growth: Management Board contracts of Andreas Niedermaier and Andreas Lösler extended ahead of schedule
- EQS-PVR: Alzchem Group AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
- EQS-Adhoc: Alzchem Group AG: Alzchem Group AG Resolves Share Buyback of up to 10 Million Euros
- EQS-News: Alzchem Group AG approves growth investments of around EUR 120 million for additional capacity in the sports, food and health sectors
- EQS-Adhoc: Alzchem Group AG: Alzchem Group AG: Investment program of around 120 million euros approved for further capacity expansion in creatine products
More ▼
